Iberdomide vs. Observation Post Ide-Cel CAR-T

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Near Add Your Location

Sorting 73 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Aurora West Allis Medical Center
West Allis, WI
  • Accepting patients
Swedish - First Hill Campus
Seattle, WA
  • Accepting patients
Vince Lombardi Cancer Clinic
Two Rivers, WI
  • Accepting patients
Providence Oncology and Hematology - Eastside
Providence Cancer Institute Franz Clinic
Portland, OR
  • Accepting patients
Cedars-Sinai Medical Center - UCLA School of Medicine
Samuel Oschin Comprehensive Cancer Institute
Los Angeles, CA
  • Not currently accepting
  • Show Principal Investigator
Nebraska Medicine (Village Pointe)
Omaha, NE
  • Accepting patients
  • Show Principal Investigator
Houston Methodist Baytown Hospital
Baytown, TX
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 788-8038

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.